ArticleCells2022

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with

Olga Alexandra Sidorova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.